Showing results (11-20 of 237) with videos related to
Sort By:
Pageof 24
NPJ Regenerative Medicine|December 5, 2024
Attenuation of skin injury by a MARCO targeting PLGA nanoparticleUmmiye V Onay, Dan Xu, Dauren Biyashev, et al.Frontiers in Immunology|October 30, 2020
Potential for Targeting Myeloid Cells in Controlling CNS InflammationIgal Ifergan, Stephen D MillerNature Communications|March 24, 2026
Antigen-specific immunotherapy with a CD4<sup>+</sup> T cell neoepitope restrains CD8<sup>+</sup> T cell differentiation in murine pancreatic islet graftsJames E DiLisio, K Scott Beard, Tobias Neef, et al.Plos One|April 16, 2011
CNS expression of B7-H1 regulates pro-inflammatory cytokine production and alters severity of Theiler's virus-induced demyelinating diseaseD'Anne S Duncan, Stephen D MillerCellular Immunology|April 9, 2014
Molecular control of monocyte developmentRachael L Terry, Stephen D MillerNeurological Research|October 4, 2005
Role of immunologic cross-reactivity in neurological diseasesAnne M Ercolini, Stephen D MillerDrugs of Today (Barcelona, Spain : 1998)|October 29, 2004
Towards cannabis and cannabinoid treatment of multiple sclerosisJ Ludovic Croxford, Stephen D MillerJournal of Autoimmunity|February 10, 2007
Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivitiesCassandra E Smith, Stephen D MillerJournal of Immunology (Baltimore, Md. : 1950)|February 6, 2007
Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitisDanielle M Turley, Stephen D MillerResults and Problems in Cell Differentiation|January 9, 2009
Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosisDanielle M Turley, Stephen D MillerPageof 24